Hypomethylating agents (HMAs) effect on myelodysplastic/myeloproliferative neoplasm unclassifiable (MDS/MPN-U): single institution experience

التفاصيل البيبلوغرافية
العنوان: Hypomethylating agents (HMAs) effect on myelodysplastic/myeloproliferative neoplasm unclassifiable (MDS/MPN-U): single institution experience
المؤلفون: William J. Hogan, Ahmed K. Abou Hussein, Mark R. Litzow, Naseema Gangat, Aref Al-Kali, Mrinal M. Patnaik, Michelle A. Elliott, Darci Zblewski, Shahrukh K. Hashmi
المصدر: Leukemia & Lymphoma. 59:2737-2739
بيانات النشر: Informa UK Limited, 2018.
سنة النشر: 2018
مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Myeloid, Unclassifiable MDS, business.industry, Myelodysplastic/Myeloproliferative Neoplasm, Chronic myelomonocytic leukemia, Hematology, medicine.disease, Clinical trial, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, medicine.anatomical_structure, hemic and lymphatic diseases, 030220 oncology & carcinogenesis, Internal medicine, Atypical chronic myeloid leukemia, Medicine, Single institution, business, Survival rate
الوصف: Myelodysplastic/myeloproliferative overlap neoplasms (MDS/MPNs) are rare myeloid disorders that comprise chronic myelomonocytic leukemia (CMML), atypical chronic myeloid leukemia (aCML), juvenile m...
تدمد: 1029-2403
1042-8194
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::bf24c012371398507aeae726cbc02dc6
https://doi.org/10.1080/10428194.2018.1436705
رقم الأكسشن: edsair.doi...........bf24c012371398507aeae726cbc02dc6
قاعدة البيانات: OpenAIRE